1,5-anhydroglucitol has been researched along with Disease Exacerbation in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel-Hamid, AZ; El-Maraghy, SA; Hanafy, MM; Lindeque, JZ; Shahin, NN | 1 |
| Ballantyne, CM; Ballew, SH; Coresh, J; Ding, N; Folsom, AR; Heiss, G; Hirsch, AT; Hoogeveen, RC; Jaar, B; Kwak, L; Matsushita, K; Salameh, M; Selvin, E; Sharrett, AR | 1 |
| Chayama, K; Hashiba, M; Hirose, A; Hyogo, H; Ikeda, Y; Ishikawa, Y; Masuda, K; Munekage, K; Nagata, Y; Noguchi, S; Nozaki-Fujimura, Y; Ochi, T; Okamoto, N; Ono, M; Saibara, T; Suganuma, N; Yoshioka, R | 1 |
3 other study(ies) available for 1,5-anhydroglucitol and Disease Exacerbation
| Article | Year |
|---|---|
Time-based investigation of urinary metabolic markers for Type 2 diabetes: Metabolomics approach for diabetes management.
Topics: Animals; Biomarkers; Carnitine; Cluster Analysis; Deoxyglucose; Diabetes Mellitus, Experimental; Disease Progression; Fructose; Fucose; Galactose; Glycosuria; Inositol; Magnetic Resonance Spectroscopy; Male; Metabolome; Metabolomics; Phenylalanine; Rats; Rats, Wistar; Streptozocin; Taurine; Time Factors | 2021 |
Traditional and nontraditional glycemic markers and risk of peripheral artery disease: The Atherosclerosis Risk in Communities (ARIC) study.
Topics: Biomarkers; Blood Glucose; Critical Illness; Deoxyglucose; Diabetes Mellitus; Diabetic Foot; Disease Progression; Female; Fructosamine; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Incidence; Ischemia; Lower Extremity; Male; Middle Aged; Peripheral Arterial Disease; Predictive Value of Tests; Prevalence; Prognosis; Prospective Studies; Risk Assessment; Risk Factors; Serum Albumin; Severity of Illness Index; Time Factors; United States | 2018 |
Glycemic variability is an independent predictive factor for development of hepatic fibrosis in nonalcoholic fatty liver disease.
Topics: Adult; Aged; Blood Glucose; Deoxyglucose; Disease Progression; Fatty Liver; Female; Glycated Hemoglobin; Humans; Insulin; Insulin Secretion; Liver Cirrhosis; Male; Middle Aged; Multivariate Analysis; Non-alcoholic Fatty Liver Disease; Prognosis | 2013 |